News tagged with liver enzyme
NAFLD increases the risk of early atherosclerotic lesions
A study presented today at the International Liver Congress 2013 – which evaluated the relationship between non-alcoholic fatty liver disease (NAFLD), early predictors of atherosclerosis and the 10-year Framingham risk ...
Diseases, Conditions, Syndromes
Apr 26, 2013 |
not rated yet |
0
A new treatment option for alcohol dependence: Reduced consumption rather than abstinence
A potential new treatment for alcoholism called nalmefene is effective and safe for reducing alcohol consumption in alcohol dependent individuals, says a new study published this week in Biological Psychiatry.
Psychology & Psychiatry
Apr 11, 2013 |
5 / 5 (1) |
1
Cancers don't sleep: The Myc oncogene can disrupt circadian rhythm
The Myc oncogene can disrupt the 24-hour internal rhythm in cancer cells. Postdoctoral fellow Brian Altman, PhD, and graduate student Annie Hsieh, MD, both from the in the lab of Chi Van Dang, MD, PhD, director of the Abramson ...
Cancer
Apr 09, 2013 |
3 / 5 (2) |
0
|
Fulyzaq approved for ART-related diarrhea in HIV/AIDS
(HealthDay)—The first medication to treat diarrhea in people with HIV/AIDS who take antiretroviral drugs has been approved by the U.S. Food and Drug Administration.
Medications
Jan 03, 2013 |
not rated yet |
0
Ability to metabolize tamoxifen affects breast cancer outcomes, study confirms
For nearly a decade, breast cancer researchers studying the hormone therapy tamoxifen have been divided as to whether genetic differences in a liver enzyme affect the drug's effectiveness and the likelihood breast cancer ...
Cancer
Dec 27, 2012 |
not rated yet |
0
|
Xeljanz approved for rheumatoid arthritis
(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.
Arthritis & Rheumatism
Nov 07, 2012 |
not rated yet |
0
Oxidative stress and altered gene expression occurs in a metabolic liver disease model
A team of researchers under the direction of Dr. Jeffrey Teckman in the Department of Pediatrics at St. Louis University, have demonstrated that oxidative stress occurs in a genetic model of alpha-1-antitrypsin deficiency. ...
Medical research
Oct 30, 2012 |
not rated yet |
0
Stivarga approved for advanced colorectal cancer
(HealthDay)—Stivarga (regorafenib) has been approved by the U.S. Food and Drug Administration to treat colorectal cancer that has spread despite prior treatment.
Medications
Sep 27, 2012 |
not rated yet |
0
BIDMC and Diagnostics For All create first low-cost, paper-based, point of care liver function test
A new postage stamp-sized, paper-based device could provide a simple and reliable way to monitor for liver damage at a cost of only pennies per test, say researchers at Beth Israel Deaconess Medical Center (BIDMC) and Diagnostics ...
Diseases, Conditions, Syndromes
Sep 19, 2012 |
not rated yet |
0
|
How genetics shape our addictions: Genes predict the brain's reaction to smoking
Have you ever wondered why some people find it so much easier to stop smoking than others? New research shows that vulnerability to smoking addiction is shaped by our genes.
Genetics
Sep 11, 2012 |
5 / 5 (1) |
0
|
Four acute mushroom poisonings in two weeks
On September 12, 2011, a Springfield, Virginia man arrived at MedStar Georgetown University Hospital (MGUH) in the early stages of liver failure. The man had mistakenly eaten poisonous mushrooms, handpicked from his yard. ...
Diseases, Conditions, Syndromes
May 20, 2012 |
not rated yet |
1
Liver tells all and reveals truth about fat
Dr Barbara Fam from the University's Molecular Obesity Laboratory group at Austin Health with Associate Professor Sof Andrikopoulos have discovered that the liver can directly talk to the brain to control the amount of food ...
Diabetes
Apr 20, 2012 |
not rated yet |
0
|
American Heart Association comment: FDA announces safety changes on labeling for some statins
The United States Food and Drug Administration (FDA) announced it is revising safety information on the labels of some statins (cholesterol lowering drugs).
Cardiology
Feb 29, 2012 |
not rated yet |
0
Gut hormone leads to weight loss in overweight or obese patients
Giving overweight or obese patients a gut hormone that suppresses appetite leads to clinically beneficial weight loss as well as reduced blood pressure and cholesterol levels, finds a study published in the British Medical ...
Overweight and Obesity
Jan 10, 2012 |
not rated yet |
1
|
Genetic test for Plavix use may be unneeded: study
A new study published Wednesday cast doubt on the usefulness of a genetic test for patients taking the anti-coagulant drug Plavix, calling into question last year's FDA warning about the blood thinner.
Medications
Dec 29, 2011 |
not rated yet |
0
